Dr. Jeffrey C. Lerner, President and Chief Executive Officer of the ECRI Institute, explains how his organization considers comparative effectiveness research (CER) and how this research helps in understanding how treatments work. He also highlights ECRI and FDA's November 29-30 conference, "Patient-Centeredness in Policy and Practice: A conference on evidence, programs, and implications."
Link to this comment:
All Comments (0)